GENOMICS has always had a strong sense of culture and community - you can feel it the moment you walk through the door. I felt it on my first day, and it’s a big part of why people join and why they stay. But until now, we’ve never taken the time to put into words what truly makes us us.

Our CEO and Founder, Professor Sir Peter Donnelly, was interviewed on BBC News regarding the UK Government's plans for investment in the Oxford and Cambridge region.

Genomics has been recognised in the Sunday Times 100 Tech 2025, as one of Britain’s fastest growing private tech companies. The prestigious ranking was published this morning on The Times website. The list ranks Britain’s private tech companies on growth in annual revenues, measured over three years. There are two tables which make up the 100 Tech: the top 50 software, and the top 50 hardware companies. We ranked 41 in the hardware category.

The Times covered our latest work in preventing obesity using genetics, and the highlights from the keynote speech given by our CEO and Founder Professor Sir Peter Donnelly at the Bupa Healthcare Symposium: Unboxing Digital Health2024. More than half of adults across the world are overweight or suffering from obesity according to the World Health Organisation, but genomic sequencing and a proactive, personalised and preventative approach to treatment could help to solve the global obesity crisis.

The Financial Times covered our latest ground-breaking research, showing that gene screening can cut early disease deaths by 25%. A simple genetic screening test has the potential to stop almost a quarter of premature preventable deaths from common diseases including breast cancer, diabetes and hypertension, by identifying those most at risk.

Our research shows very high risk individuals reached the risk levels associated with usual starting screening ages 12.4 years earlier, on average. In other words, if a screening programme were devised on the basis of the average risk facing a 50-year-old, this high risk group would have the same predicted risk at the age of 37.6. Recommendations for earlier screening for genetically very high risk groups ranged from four years in advance for abdominal aortic aneurysm, to 22 years for hypertension.

The Telegraph covered our latest study on obesity, which showed that individuals with a genetic risk score for high BMI, calculated using Genomics’ proprietary polygenic risk scores (PRS), were 10 times more likely to develop obesity later in life - even at the same activity levels and calorie intake.

Our research shows that those at high genetic risk of obesity will need personalised support to help them stay at, or return to, a healthy weight.

Genomics releases new research showing significant link between genetic risk and obesity